(Q36304789)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16266194%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Biologic therapy for inflammatory bowel disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16266194%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

8 January 2020

main subject

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16266194%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Gabriele Bianchi Porro

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16266194%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16266194%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16266194%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16266194%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16266194%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

2253-2286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16266194%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-200565160-00002

8 January 2020

exact match

0 references

cites work

Inflammatory bowel disease: new insights into pathogenesis and treatment

1 reference

12 December 2020

Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease

1 reference

12 December 2020

Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis

1 reference

12 December 2020

The state of the art in the management of inflammatory bowel disease.

1 reference

12 December 2020

Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.

1 reference

12 December 2020

Tumor necrosis factor: biology and therapeutic inhibitors

1 reference

12 December 2020

Infliximab in the treatment of Crohn's disease: a user's guide for clinicians

1 reference

12 December 2020

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.

1 reference

12 December 2020

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

12 December 2020

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

1 reference

12 December 2020

Inhibition of tumor necrosis factor mRNA translation by a rationally designed immunomodulatory peptide

1 reference

12 December 2020

The indigenous gastrointestinal microflora

1 reference

12 December 2020

T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans

1 reference

12 December 2020

Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects

1 reference

12 December 2020

Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease.

1 reference

12 December 2020

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

12 December 2020

Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis

1 reference

12 December 2020

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

1 reference

12 December 2020

Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis

1 reference

12 December 2020

Infliximab for treatment of steroid-refractory ulcerative colitis

1 reference

12 December 2020

Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor

1 reference

12 December 2020

Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial

1 reference

12 December 2020

HuM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro

1 reference

12 December 2020

A major role for matrix metalloproteinases in T cell injury in the gut.

1 reference

12 December 2020

Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables

1 reference

12 December 2020

Infliximab in treatment of Crohn's disease: the Milan experience

1 reference

12 December 2020

IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology

1 reference

12 December 2020

Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis

1 reference

12 December 2020

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

1 reference

12 December 2020

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

1 reference

12 December 2020

A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism

1 reference

12 December 2020

Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies

1 reference

12 December 2020

Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production

1 reference

12 December 2020

Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study

1 reference

12 December 2020

Efficacy of keratinocyte growth factor-2 in dextran sulfate sodium-induced murine colitis

1 reference

12 December 2020

Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

1 reference

12 December 2020

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

1 reference

12 December 2020

A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin

1 reference

12 December 2020

Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease

1 reference

12 December 2020

Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?

1 reference

12 December 2020

NF-kappaB signaling proteins as therapeutic targets for inflammatory bowel diseases

1 reference

12 December 2020

Inflammatory bowel disease approaching the 3rd millennium: pathogenesis and therapeutic implications?

1 reference

12 December 2020

IL-6 is required for the development of Th1 cell-mediated murine colitis

1 reference

12 December 2020

Infliximab treatment for Crohn's disease: one-year experience in a Dutch academic hospital

1 reference

12 December 2020

Treatment of active Crohn's disease with onercept (recombinant human soluble p55 tumour necrosis factor receptor): results of a randomized, open-label, pilot study

1 reference

12 December 2020

Crohn's disease: genetic susceptibility, bacteria, and innate immunity

1 reference

12 December 2020

1 reference

12 December 2020

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

1 reference

12 December 2020

Infliximab in the treatment of medically refractory indeterminate colitis

1 reference

12 December 2020

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group

1 reference

12 December 2020

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

1 reference

12 December 2020

Biologicals: principles, techniques and mechanisms of action

1 reference

12 December 2020

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

1 reference

12 December 2020

The immunology of inflammatory bowel disease

1 reference

12 December 2020

RDP58, a locally active TNF inhibitor, is effective in the dextran sulphate mouse model of chronic colitis

1 reference

12 December 2020

In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells.

1 reference

12 December 2020

Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms

1 reference

12 December 2020

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

1 reference

12 December 2020

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

12 December 2020

Transfer of interleukin-4 and interleukin-10 in patients with severe inflammatory bowel disease of the rectum

1 reference

12 December 2020

IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells

1 reference

12 December 2020

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

1 reference

12 December 2020

An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Emerging biologic therapies in inflammatory bowel disease.

1 reference

12 December 2020

Dysregulation of intestinal mucosal immunity: implications in inflammatory bowel disease

1 reference

12 December 2020

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group

1 reference

12 December 2020

Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease

1 reference

12 December 2020

Smoking and inflammatory bowel disease. A case control study

1 reference

12 December 2020

Growth factors in inflammatory bowel disease

1 reference

12 December 2020

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease

1 reference

12 December 2020

Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease

1 reference

12 December 2020

A preliminary study of growth hormone therapy for Crohn's disease

1 reference

12 December 2020

Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease

1 reference

12 December 2020

Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study

1 reference

12 December 2020

Lymphocyte homing and homeostasis

1 reference

12 December 2020

Inflammatory granuloma formation is mediated by TNF-alpha-inducible intercellular adhesion molecule-1

1 reference

12 December 2020

Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat.

1 reference

12 December 2020

An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis

1 reference

12 December 2020

A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease.

1 reference

12 December 2020

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

1 reference

12 December 2020

Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis

1 reference

12 December 2020

Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease

1 reference

12 December 2020

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

1 reference

12 December 2020

Use of Lactobacillus-GG in paediatric Crohn's disease

1 reference

12 December 2020

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

1 reference

12 December 2020

Treatment of severe Crohn's disease with anti-CD4 monoclonal antibody.

1 reference

12 December 2020

Regulation of the mucosal epithelial barrier

1 reference

12 December 2020

Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation

1 reference

12 December 2020

The biology of interleukin-6

1 reference

12 December 2020

Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA.

1 reference

12 December 2020

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

The nuclear receptor superfamily: the second decade

1 reference

12 December 2020

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

1 reference

12 December 2020

Nonspecific inflammatory bowel disease and smoking

1 reference

12 December 2020

Azathioprine for maintaining remission of Crohn's disease

1 reference

12 December 2020

IL-12 and Th1 immune responses in human Peyer's patches

1 reference

12 December 2020

Predictors of response to infliximab in patients with Crohn's disease

1 reference

12 December 2020

Infliximab for patients with refractory ulcerative colitis

1 reference

12 December 2020

Biologics in inflammatory bowel disease: how much progress have we made?

1 reference

12 December 2020

Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.

1 reference

12 December 2020

Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody

1 reference

12 December 2020

The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10.

1 reference

12 December 2020

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

1 reference

12 December 2020

MMPs in the gut: inflammation hits the matrix

1 reference

12 December 2020

Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease

1 reference

12 December 2020

Biologic therapy for inflammatory bowel disease

1 reference

12 December 2020

CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study

1 reference

12 December 2020

Methotrexate for the Treatment of Crohn's Disease

1 reference

12 December 2020

Antibodies to interleukin 12 abrogate established experimental colitis in mice

1 reference

12 December 2020

A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis

1 reference

12 December 2020

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group

1 reference

12 December 2020

Ulcerative colitis and Crohn's disease

1 reference

12 December 2020

Therapeutic monoclonal antibodies

1 reference

12 December 2020

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

12 December 2020

Trichuris suis therapy in Crohn's disease

1 reference

12 December 2020

Smoking and colonic mucus in ulcerative colitis

1 reference

12 December 2020

Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats

1 reference

12 December 2020

Perianal fistulae following infliximab treatment: clinical and endosonographic outcome.

1 reference

12 December 2020

Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.

1 reference

12 December 2020

Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis

1 reference

12 December 2020

High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy

1 reference

12 December 2020

Medical therapy for inflammatory bowel disease

1 reference

12 December 2020

Clinical use of Infliximab in Crohn's disease: the Edinburgh experience

1 reference

12 December 2020

Review article: mild to moderate Crohn's disease--defining the basis for a new treatment algorithm

1 reference

12 December 2020

Antisense-oligonucleotide therapy

1 reference

12 December 2020

CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trial

1 reference

12 December 2020

Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats

1 reference

12 December 2020

Autoimmunity and apoptosis: the Crohn's connection

1 reference

12 December 2020

Management of Crohn's disease of the ileoanal pouch with infliximab.

1 reference

12 December 2020

Inflammatory bowel disease: etiology and pathogenesis

1 reference

12 December 2020

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

12 December 2020

Immunological disorders in inflammatory bowel disease and immunotherapeutic implications

1 reference

12 December 2020

Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study

1 reference

12 December 2020

Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trials

1 reference

12 December 2020

General principles of medical therapy of inflammatory bowel disease

1 reference

12 December 2020

Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease

1 reference

12 December 2020

Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression

1 reference

12 December 2020

Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production

1 reference

12 December 2020

Association of glycogen storage disease 1b and Crohn disease: results of a North American survey

1 reference

12 December 2020

T cells in inflammatory bowel disease: protective and pathogenic roles.

1 reference

12 December 2020

Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives

1 reference

12 December 2020

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis

1 reference

12 December 2020

NOD2/CARD15 does not influence response to infliximab in Crohn's disease

1 reference

12 December 2020

Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease

1 reference

12 December 2020

Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease

1 reference

12 December 2020

Infliximab in Crohn's disease: first anniversary clinical experience

1 reference

12 December 2020

Enteric Microflora in IBD: Pathogens or Commensals?

1 reference

12 December 2020

Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides.

1 reference

12 December 2020

Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3

1 reference

12 December 2020

High Fas ligand expression on lymphocytes in lesions of ulcerative colitis

1 reference

12 December 2020

Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis

1 reference

12 December 2020

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

1 reference

12 December 2020

[Peroxisome proliferator-activated receptor (PPAR) gamma: a new target for the treatment of inflammatory bowel disease]

1 reference

12 December 2020

Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12

1 reference

12 December 2020

Natalizumab for active Crohn's disease

1 reference

12 December 2020

Clinical experience with infliximab therapy in 100 patients with Crohn's disease

1 reference

12 December 2020

Smoking, humoral immunity, and ulcerative colitis

1 reference

12 December 2020

A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease.

1 reference

12 December 2020

Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients.

1 reference

12 December 2020

Infliximab-induced lupus in Crohn's disease: a case report.

1 reference

12 December 2020

The immune system. Second of two parts

1 reference

12 December 2020

The organization, promoter analysis, and expression of the human PPARgamma gene

1 reference

12 December 2020

Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy

1 reference

12 December 2020

Optimizing anti-TNF treatment in inflammatory bowel disease

1 reference

12 December 2020

Sargramostim for active Crohn's disease

1 reference

12 December 2020

Interleukin-6 in biology and medicine

1 reference

12 December 2020

Novel approaches to treating inflammatory bowel disease: targeting alpha-4 integrin

1 reference

12 December 2020

Somatic gene therapy in gastroenterology: approaches and applications

1 reference

12 December 2020

Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases

1 reference

12 December 2020

Anti-interleukin-12 antibody for active Crohn's disease

1 reference

12 December 2020

Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time

1 reference

12 December 2020

Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry

1 reference

12 December 2020

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease

1 reference

12 December 2020

A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy.

1 reference

12 December 2020

1 reference

12 December 2020

Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

1 reference

12 December 2020

Characterization of the in vitro and in vivo activity of monoclonal antibodies to human IL-18

1 reference

12 December 2020

Genetic markers may predict disease behavior in patients with ulcerative colitis

1 reference

12 December 2020

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

12 December 2020

Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance.

1 reference

12 December 2020

A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling

1 reference

12 December 2020

Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease

1 reference

12 December 2020

ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease

1 reference

12 December 2020

Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease

1 reference

12 December 2020

Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease

1 reference

12 December 2020

Management of Crohn's disease in adults

1 reference

12 December 2020

Successful management of Crohn's disease of the ileoanal pouch with infliximab

1 reference

12 December 2020

Infliximab maintenance therapy for fistulizing Crohn's disease

1 reference

12 December 2020

NF-kappa B may determine whether epithelial cell--microbial interactions in the intestine are hostile or friendly

1 reference

12 December 2020

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

1 reference

12 December 2020

Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI

1 reference

12 December 2020

An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease

1 reference

12 December 2020

1 reference

12 December 2020

The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study

1 reference

12 December 2020

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice

1 reference

12 December 2020

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

1 reference

12 December 2020

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

1 reference

12 December 2020

Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients

1 reference

12 December 2020

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

1 reference

12 December 2020